Boehringer Ingelheim and IBM link up for blockchain-powered clinical trials in Canada

Boehringer Ingelheim and IBM link up for blockchain-powered clinical trials in Canada

Source: 
Fierce Biotech
snippet: 

The Canada-based units of Boehringer Ingelheim and IBM will work together to employ blockchain recordkeeping technology in clinical trials, in what they say will be a first in the country.